Post Author: Oluyemisi Famuyiwa, MD
Oluyemisi (Yemi) Famuyiwa is a renowned fertility specialist and founder, Montgomery Fertility Center, committed to guiding individuals and couples on their path to parenthood with personalized care. With a background in obstetrics and gynecology from Georgetown University Hospital and reproductive endocrinology and infertility from the National Institutes of Health, she offers cutting-edge treatments like IVF and genetic testing. She can be reached on Linktr.ee, LinkedIn, YouTube, Facebook, Instagram @montgomeryfertility, and X @MontgomeryF_C.
Dr. Famuyiwa is dedicated to advancing fertility care through research, publications, and educational efforts, including hosting the Fertile Talks podcast. Beyond her clinic, she advocates holistic health and enjoys nature walks. Recognized for her excellence, she is a Castle Connolly Top Doctor and a Women Who Move Maryland honoree. Dr. Famuyiwa’s participation in the Zenith Total Health Expo 2024 reflects her commitment to empowering individuals with knowledge about nutrition, lifestyle, and fertility.
She is the author of “IGF-I and Uterine Growth,” a chapter in the Excerpta Medical International Congress Series, 1997. This work delves into the significant role of Insulin-like Growth Factor I (IGF-I) in uterine development. She also authored “Sex Steroid Regulation of IGF System Gene Expression and Proliferation in Primate Myometrium,” published in the Journal of Clinical Endocrinology and Metabolism in 1996, which explores the regulation of IGF system gene expression by sex steroids and its impact on cellular proliferation in the primate myometrium.
Oluyemisi (Yemi) Famuyiwa is a renowned fertility specialist and founder, Montgomery Fertility Center, committed to guiding individuals and couples on their path to parenthood with personalized care. With a background in obstetrics and gynecology from Georgetown University Hospital and reproductive endocrinology and infertility from the National Institutes of Health, she offers cutting-edge treatments like IVF and genetic testing. She can be reached on Linktr.ee, LinkedIn, YouTube, Facebook, Instagram @montgomeryfertility, and X @MontgomeryF_C.
Dr. Famuyiwa is dedicated to advancing fertility care through research, publications, and educational efforts, including hosting the Fertile Talks podcast. Beyond her clinic, she advocates holistic health and enjoys nature walks. Recognized for her excellence, she is a Castle Connolly Top Doctor and a Women Who Move Maryland honoree. Dr. Famuyiwa's participation in the Zenith Total Health Expo 2024 reflects her commitment to empowering individuals with knowledge about nutrition, lifestyle, and fertility.
She is the author of "IGF-I and Uterine Growth," a chapter in the Excerpta Medical International Congress Series, 1997. This work delves into the significant role of Insulin-like Growth Factor I (IGF-I) in uterine development. She also authored "Sex Steroid Regulation of IGF System Gene Expression and Proliferation in Primate Myometrium," published in the Journal of Clinical Endocrinology and Metabolism in 1996, which explores the regulation of IGF system gene expression by sex steroids and its impact on cellular proliferation in the primate myometrium.
Epigenetics has revolutionized our understanding of how lifestyle factors—such as diet, stress, exercise, and environmental exposures—affect fertility. Unlike genetic mutations, which change the DNA sequence, epigenetic changes modify how genes are expressed without altering the DNA itself. These changes occur through mechanisms such as DNA methylation and histone modifications, and they play a critical role in fertility. Even more intriguing, these epigenetic changes can be passed down to future generations …
Read more…
In recent years, e-cigarettes have emerged as a popular alternative to traditional cigarettes, often marketed as a safer choice. However, accumulating evidence reveals that e-cigarettes pose significant risks, particularly to reproductive health. This concern is especially urgent given the ongoing decline in fertility rates across the United States, which have reached historic lows in recent years. As a reproductive specialist, I find it crucial to address these risks and emphasize …
Read more…
Fertility treatments are a challenging journey filled with emotional highs and lows. For many, these treatments represent the hope of starting or growing a family. However, one of the less obvious but critical aspects of this journey involves pharmacy benefit companies (PBCs). These companies play a significant role in determining access to fertility medications, and their influence can create unexpected barriers for patients and health care providers alike.
Pharmacy benefit companies …
Read more…
Microplastics, tiny plastic particles less than 5 mm in size, have permeated our environment, showing up in oceans, air, and even our food. These particles are a growing concern due to their potential impact on human health and fertility. Recent studies, including one by the American College of Obstetricians and Gynecologists (ACOG), have highlighted the risks associated with microplastic exposure. This article delves into what microplastics are, how they affect …
Read more…
